BioTelemetry, Inc. and Well Bridge Health, Inc. announced the formation of a partnership to commercialize a novel approach to the management and remote monitoring of CHF patients. BioTelemetry has provided Wellbridge Health initial funding in the form of a convertible note.
1st Jan change | Capi. | |
---|---|---|
+19.32% | 8.35TCr | |
-21.99% | 7.54TCr | |
+2.32% | 2.67TCr | |
-5.06% | 1.82TCr | |
+6.95% | 1.81TCr | |
+7.69% | 1.65TCr | |
+76.20% | 1.41TCr | |
+76.56% | 1.3TCr | |
-27.89% | 1.27TCr |